ADT1222-Erlizumab Biosimilar-Anti-ITGB2/CD18 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1222 |
Product Name |
ADT1222-Erlizumab Biosimilar-Anti-ITGB2/CD18 mAb-Research Grade |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse ITGB2 antibody, anti-ITGB2 antibody, anti ITGB2 antibody, recombinant ITGB2, ITGB2 antibody, anti-ITGB2 monoclonal antibody, ITGB2 antibodies, ITGB2 recombinant antibody, ITGB2 blocking antibody, CD18 recombinant antibody, CD18 blocking antibody |
|
Alias |
YFC51.1 |
Host |
CHO Cells |
Species |
Human |
Target |
ITGB2/CD18 |
Gene ID |
3689 |
Isotype |
IgG1-nd |
Size |
1mg, 5mg |
Research Area |
Immunology |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Conley HE, et al. Biomolecules, 2023 May 26. PMID 37371473
2. Liu H, et al. Front Endocrinol (Lausanne), 2022. PMID 36714574
3. Ma Q, et al. Blood, 2022 Jun 9. PMID 35303071
|